发明名称 IMMUNOTHERAPEUTIC COMBINATIONS FOR THE TREATMENT OF TUMORS THAT OVER-EXPRESS GANGLIOSIDES
摘要 <p>The invention relates to the field of immunology and specifically to immunotherapeutic combinations that are used to impede the growth of tumour cells and/or to eliminate said cells. The present invention can be used to observe a therapeutic antitumour effect by combining idiotypic vaccines having an antiganglioside antibody (Ab1) as the active principle thereof with idiotypic vaccines, the active principle of which is an anti-idiotype antibody obtained against an antiganglioside antibody (Ab2), or with vaccines, the active principle of which is one or more gangliosides. The invention relates to combinations of said vaccines which produce a synergism of the antitumour effect which is induced separately by each of the vaccines. Said combinations can be applied to patients in different clinical states with tumours that overexpress gangliosides.</p>
申请公布号 CA2443372(C) 申请公布日期 2013.05.28
申请号 CA20022443372 申请日期 2002.04.08
申请人 CENTRO DE INMUNOLOGIA MOLECULAR;FERNANDEZ MOLINA, LUIS ENRIQUE;VAZQUEZ LOPEZ, ANA MARIA;PEREZ RODRIGUEZ, ROLANDO;PEREZ GONZALEZ, ALEXIS;CARR PEREZ, ADRIANA;DIAZ RODRIGUEZ, YILDIAN;ALFONSO FERNANDEZ, MAURO A. 发明人 FERNANDEZ MOLINA, LUIS ENRIQUE;VAZQUEZ LOPEZ, ANA MARIA;PEREZ RODRIGUEZ, ROLANDO;PEREZ GONZALEZ, ALEXIS;CARR PEREZ, ADRIANA;DIAZ RODRIGUEZ, YILDIAN;ALFONSO FERNANDEZ, MAURO A.
分类号 C07K16/30;C12N15/09;A61K31/70;A61K31/7032;A61K31/739;A61K39/00;A61K39/395;A61P35/00;A61P35/04;A61P37/00;A61P37/04;A61P43/00;C07K16/00;C07K16/18;C07K16/42;C07K16/46;C12N1/15;C12N1/19;C12N1/21;C12N5/10;C12N5/20;C12P21/08 主分类号 C07K16/30
代理机构 代理人
主权项
地址